Open Government Canada
Registration Decision RD2021-01, Trifludimoxazin, Vulcarus and Voraxor
Published by Health Canada | Santé Canada
About this dataset
This decision is consistent with the Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor, which contains a detailed evaluation of the information submitted in support of this registration.